Cardiac Biomarker Measurement After Elective PCI in Older Patients
Cardiac Biomarker Measurement After Elective PCI in Older Patients
In conclusion, most PCI centers do not perform routine postprocedure cardiac biomarker measurement; therefore, older patients undergoing elective PCI infrequently have postprocedure biomarker measurements obtained. A substantial proportion of patients with complex procedures and intraprocedural complications did not have postprocedure biomarker measurements, which may represent a gap in adherence to PCI guidelines. Patients with CK-MB measurement had greater use of evidence-based therapies, and patients treated at centers with more routine post-PCI biomarker measurement had significantly lower risk-adjusted long-term mortality compared with patients treated at centers without routine measurement. These results suggest that hospitals that routinely measure CK-MB levels after elective PCI have a better quality of care culture that translates into improved outcomes.
Conclusions
In conclusion, most PCI centers do not perform routine postprocedure cardiac biomarker measurement; therefore, older patients undergoing elective PCI infrequently have postprocedure biomarker measurements obtained. A substantial proportion of patients with complex procedures and intraprocedural complications did not have postprocedure biomarker measurements, which may represent a gap in adherence to PCI guidelines. Patients with CK-MB measurement had greater use of evidence-based therapies, and patients treated at centers with more routine post-PCI biomarker measurement had significantly lower risk-adjusted long-term mortality compared with patients treated at centers without routine measurement. These results suggest that hospitals that routinely measure CK-MB levels after elective PCI have a better quality of care culture that translates into improved outcomes.
